BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22048626)

  • 1. Medical oncology: clinical value of circulating tumor cells in breast cancer.
    Sleijfer S; Foekens JA
    Nat Rev Clin Oncol; 2011 Nov; 8(12):696-8. PubMed ID: 22048626
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Circulation Tumor Cells Detection in Diagnosis and Treatment of Breast Tumors.
    Cai F; Cen C; Cai L; Falar Luis MA; Biskup E
    Rejuvenation Res; 2019 Dec; 22(6):498-502. PubMed ID: 30712469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells in Breast Cancer.
    Liang DH; Hall C; Lucci A
    Recent Results Cancer Res; 2020; 215():127-145. PubMed ID: 31605227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer.
    Cueva Bañuelos JF; Rodríguez López C; Cortegoso Mosquera A; Palacios Ozores P; Curiel García T
    Adv Exp Med Biol; 2020; 1220():147-164. PubMed ID: 32304085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in breast cancer.
    Banys M; Müller V; Melcher C; Aktas B; Kasimir-Bauer S; Hagenbeck C; Hartkopf A; Fehm T
    Clin Chim Acta; 2013 Aug; 423():39-45. PubMed ID: 23623805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells in breast cancer--current status and perspectives.
    Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
    Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy.
    Ziogas DE; Spiliotis J; Lykoudis EG; Zografos GC; Roukos DH
    Future Oncol; 2017 Jan; 13(2):113-116. PubMed ID: 27581662
    [No Abstract]   [Full Text] [Related]  

  • 9. The Future of Precision Medicine in Oncology.
    Millner LM; Strotman LN
    Clin Lab Med; 2016 Sep; 36(3):557-73. PubMed ID: 27514468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic implications of circulating tumor cells in patients with breast cancer.
    Smerage JB; Hayes DF
    Cancer Invest; 2008 Mar; 26(2):109-14. PubMed ID: 18259939
    [No Abstract]   [Full Text] [Related]  

  • 11. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review.
    Khatami F; Aghayan HR; Sanaei M; Heshmat R; Tavangar SM; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):175-193. PubMed ID: 28282718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cells: Overview and Opportunities in Cytology.
    Sundling KE; Lowe AC
    Adv Anat Pathol; 2019 Jan; 26(1):56-63. PubMed ID: 30325755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
    Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
    Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
    Bear HD
    J Clin Oncol; 2008 Mar; 26(8):1195-7. PubMed ID: 18323543
    [No Abstract]   [Full Text] [Related]  

  • 17. Being more precise in assessing the value of precision medicine in breast cancer.
    Curigliano G
    Breast; 2016 Oct; 29():186-7. PubMed ID: 27600532
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated tumor cells: the method is the message.
    Park JW
    Breast Cancer Res Treat; 2011 Feb; 125(3):739-40. PubMed ID: 20700647
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating tumor cells in breast cancer.
    Bidard FC; Proudhon C; Pierga JY
    Mol Oncol; 2016 Mar; 10(3):418-30. PubMed ID: 26809472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.